NCT03438266

A Study of the Safety and Effectiveness of JUVÉDERM VOLUMA® XC Injectable Gel for Cheek Augmentation Using Cannula

A Multicenter, Single-blind, Randomized, Controlled Study of the Safety and Effectiveness of JUVÉDERM VOLUMA® XC Injectable Gel for Cheek Augmentation Using Cannula

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 66 (actual)
• Sponsor: Allergan · Industry
• Sex: All
• Age: 35 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

The objective of this study is to evaluate the safety and effectiveness of JUVÉDERM VOLUMA® XC injectable gel using cannula in participants seeking correction of age-related volume deficit in the mid-face.

Conditions

• Age-related Volume Deficit in the Mid-face

Interventions

Type	Name	Description
DEVICE	JUVÉDERM VOLUMA® XC injectable gel with cannula	Participants had 1 cheek treated with JUVÉDERM VOLUMA® XC injectable gel with cannula.
DEVICE	JUVÉDERM VOLUMA® XC injectable gel with needle	Participants had 1 cheek treated with JUVÉDERM VOLUMA® XC injectable gel with a needle.

Timeline

• Start date: 2018-02-05
• Primary completion: 2018-05-29
• Completion: 2018-08-02
• First posted: 2018-02-19
• Last updated: 2019-08-05
• Results posted: 2019-08-05

Locations

7 sites across 1 country: United States

Regulatory

• FDA-regulated device study